Zowall has been conducting cost evaluation studies and specializing
in economic studies for formulary submissions since 1989. For
over 10 years, Hanna Zowall was a Director of Economic Evaluations
in the Centre for the Analysis of Cost-Effective Care, Division
of Clinical Epidemiology at The Montreal General Hospital, McGill
University, Montreal, Canada.
is a co-author of medical studies published in Circulation,
of Internal Medicine, JAMA,
Care. She has served as a member of the University-Industry
Institutes of Health Research (CIHR), a major funding body in
Canada. In 2000, together with her colleagues from The Montreal
General Hospital she was a recipient of Prix IMS Health Canada for
the best cost-effectiveness study.
area of expertise includes developing databases of standard health
care costs in Canada, the United Kingdom, the United States, and
other countries, setting up the appropriate types of economic evaluation
such as cost-effectiveness, cost-benefit, cost-utility and cost-comparison,
designing prospective health economics studies by collecting, analyzing
and evaluating clinical, quality of life and economic outcomes.
Zowall has co-authored economic evaluation studies in the areas
of cardiovascular disease, prostate cancer, diabetes and HIV. She
has developed Canadian, American and British cost databases for
cardiovascular diseases, hyperlipidemia, diabetes, HIV, prostate
cancer, and other diseases.
is currently teaching health economics and the financial aspect
of health care at Concordia University and at McGill University
in Montreal, Canada.